ANGELUCCI, ADRIANO
 Distribuzione geografica
Continente #
NA - Nord America 8.373
EU - Europa 4.769
AS - Asia 4.509
SA - Sud America 433
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 18.150
Nazione #
US - Stati Uniti d'America 8.275
SG - Singapore 1.845
CN - Cina 1.031
IE - Irlanda 1.007
RU - Federazione Russa 924
DE - Germania 613
TR - Turchia 510
SE - Svezia 490
IT - Italia 469
HK - Hong Kong 464
BR - Brasile 360
VN - Vietnam 353
GB - Regno Unito 337
UA - Ucraina 281
FR - Francia 256
FI - Finlandia 200
IN - India 73
CA - Canada 57
JP - Giappone 53
BD - Bangladesh 40
CZ - Repubblica Ceca 35
BE - Belgio 32
NL - Olanda 24
MX - Messico 22
ES - Italia 20
PL - Polonia 20
AR - Argentina 19
ZA - Sudafrica 19
IQ - Iraq 18
LT - Lituania 17
KR - Corea 15
EC - Ecuador 14
MA - Marocco 12
PK - Pakistan 12
UZ - Uzbekistan 12
SA - Arabia Saudita 10
TW - Taiwan 10
VE - Venezuela 10
CO - Colombia 9
EU - Europa 9
AT - Austria 7
ID - Indonesia 7
MY - Malesia 7
PH - Filippine 7
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
PE - Perù 5
PY - Paraguay 5
UY - Uruguay 5
CH - Svizzera 4
CL - Cile 4
DZ - Algeria 4
IL - Israele 4
PA - Panama 4
PT - Portogallo 4
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SI - Slovenia 3
TH - Thailandia 3
AL - Albania 2
BN - Brunei Darussalam 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
LB - Libano 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
RO - Romania 2
TL - Timor Orientale 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CU - Cuba 1
GE - Georgia 1
GI - Gibilterra 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MU - Mauritius 1
Totale 18.144
Città #
Dallas 1.210
Singapore 1.129
Jacksonville 1.102
Chandler 1.022
Dublin 1.004
San Jose 714
Hong Kong 456
Ashburn 434
Boardman 394
Santa Clara 367
Izmir 257
Nanjing 229
San Mateo 200
The Dalles 200
New York 197
Wilmington 165
Lawrence 145
Princeton 145
Moscow 144
Ann Arbor 127
Beijing 124
Lauterbourg 118
Bremen 117
Munich 117
Ho Chi Minh City 110
L'aquila 89
Hanoi 76
Los Angeles 70
Seattle 65
Milan 64
Nanchang 61
Woodbridge 61
Shenyang 53
Mountain View 49
Hefei 48
Helsinki 48
São Paulo 46
Tokyo 43
Des Moines 41
Hebei 39
Jiaxing 39
Rome 37
Council Bluffs 35
Verona 35
Brno 32
L’Aquila 32
Shanghai 31
Brussels 30
Tianjin 30
Frankfurt am Main 29
Strasbourg 28
Kunming 27
Brooklyn 24
Columbus 24
Da Nang 23
Zhengzhou 23
Orem 22
Changsha 21
Falls Church 21
Philadelphia 20
Torre Del Greco 20
Jinan 19
Ningbo 19
Turku 19
Chicago 18
Dearborn 18
Warsaw 18
Chennai 17
Norwalk 17
Toronto 17
Denver 16
Houston 16
Stockholm 16
Belo Horizonte 15
Guangzhou 15
Hangzhou 15
London 15
Montreal 15
Boston 14
Johannesburg 14
Atlanta 13
Manchester 13
Poplar 13
Pune 13
San Francisco 13
Falkenstein 12
Haiphong 12
Pescara 12
Taizhou 12
Tashkent 12
Teramo 12
Amsterdam 11
Phoenix 11
Dhaka 10
Lanzhou 10
Lappeenranta 10
Biên Hòa 9
Düsseldorf 9
Nuremberg 9
Rio de Janeiro 9
Totale 12.201
Nome #
Evaluation of Antitumoral Activity in a 3D Cell Model of a Src Inhibitor Prodrug for Glioblastoma Treatment 445
Serum 25(OH)D seasonality in urologic patients from central Italy 217
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 203
Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions 192
Clinical correlates of plasma brain-derived neurotrophic factor in post-traumatic stress disorder spectrum after a natural disaster 158
Obesity in the elderly - On the role of adipokines in prostate cancer progression 156
Adipose-derived stem cells sustain prolonged angiogenesis through leptin secretion 155
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment 154
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 154
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 151
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer 151
Src inhibition potentiates antitumoral effect of paclitaxel by blocking tumor-induced angiogenesis. 147
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma 146
Introductory Immunology 145
Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancer 141
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 139
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 139
Src family kinases as therapeutic targets in advanced solid tumors: What we have learned so far 138
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 136
Co-evolution of stroma and neoplastic cells in prostate cancer is sustained by reprogramming energy metabolism 135
Suppression of SRC signaling is effective in reducing synergy between glioblastoma and stromal cells 135
Non-conventional role of haemoglobin beta in breast malignancy 135
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma 134
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 134
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 132
The unexpected role of Hemoglobin beta (HBB) in breast cancer. 131
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 131
c-Src inhibition decreases breast cancer-induced lethality and incidence of metastases in nude mice. 131
In-vitro approaches to investigate the detrimental effect of light on dopaminergic neurons 130
THE IMPACT OF SERUM LEPTIN AS BIOMARKER OF PROSTATE CANCER INCREASES WITH AGEING 130
Aging influences the Value of Serum Leptin as Prostate Cancer Risk Factor 128
INIBITORI DI METALLOPROTEASI DI MATRICE: PROSPETTIVE TERAPEUTICHE. EOS - JOURNAL OF IMMUNOLOGY AND IMMUNOPHARMACOLOGY, VOL.XXI – 2001 – N.1: 22-27 127
Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures 126
NF-κB: A Druggable Target in Acute Myeloid Leukemia 126
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 126
INHIBITION OF 5-ALPHA-REDUCTASE ISOFORMS IN PROSTATE CARCINOMA PRIMARY CULTURES 125
ENERGY METABOLISM OF PROSTATE CANCER CAN BE SUPPORTED BY REVERSE WARBURG EFFECT 124
Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells 124
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment 124
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 122
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 122
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 122
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 121
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02 121
Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis 120
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 120
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer 120
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 120
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 120
Plasma brain-derived neurotrophic factor in earthquake survivors with full and partial post-traumatic stress disorder 120
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 119
An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines 119
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 119
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 118
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 118
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 118
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 118
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 118
The importance of tumor stem cells in glioblastoma resistance to therapy 118
The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering 116
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro 115
A new inhibitor of EGFR/SRC activation is able to block several key molecular events in prostate cancer progression 114
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples 114
NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-D] PYRIMIDINE AND PYRROLO [2,3-D] PYRIMIDINE AND USES THEREOF 114
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells 114
Osteoblast-derived TGF beta-1 modulates matrix degrading protease expression and activity in prostate cancer cells (vol 85, pg 407, 2000) 114
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling 114
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation 114
Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4-d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant 113
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 113
Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia 113
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells 113
Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors 113
Extracellular vesicles: New endogenous shuttles for mirnas in cancer diagnosis and therapy? 113
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 112
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures 112
Targeting ddx3x helicase activity with ba103 shows promising therapeutic effects in preclinical glioblastoma models 112
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells 111
Apoptosis or programmed cell death 111
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones 111
Fenomeni adattativi dopo terapia antiandrogenica nel tumore della prostata 110
Targeting ERBB receptors to inhibit metastasis: old hopes and new certainties 109
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 109
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors 108
Surgical and Biologic Outcomes After Neoadjuvant Bicalutamide Treatment in Prostate Cancer 108
Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs) 108
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells 108
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 108
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 106
Increased BDNF levels after a trauma A pilot study on clinical and non-clinical samples, exposed or non-exposed to an earthquake 106
Apoptosi e sistema immunitario: regolazione e patologie associate 105
Possibile anti-apoptotic activity of carnitines on excitatory amino acid induced neurotoxicity 105
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 Prostate Cancer Cell Line 104
Therapeutic potential of Askina® Gel in regenerative medicine 104
Arachidonic acid sustains prostate tumor growth in bone metastasis through the COX-2-mediated production of TNF-alpha 103
La ridondanza delle vie di segnalazione intracellulari PI3K-AKT-MTOR induce la resistenza di cellule di cancro prostatico alla terapia ormonale ed ai chemoterapici in vivo ed in vitro 103
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures 102
Hypoxia Induces DPSC Differentiation versus a Neurogenic Phenotype by the Paracrine Mechanism 102
Therapeutic potential of a biomatrix (Askina gel) in regenerative medicine 100
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 99
Totale 12.731
Categoria #
all - tutte 72.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021375 0 0 0 0 0 0 0 0 0 59 255 61
2021/2022980 63 88 183 66 43 23 15 52 48 33 82 284
2022/20233.005 198 157 57 314 346 321 3 214 1.238 19 90 48
2023/2024728 99 45 40 126 53 215 12 37 2 17 20 62
2024/20252.949 74 74 233 112 373 251 373 267 639 142 240 171
2025/20266.155 253 618 955 825 600 440 1.073 230 490 671 0 0
Totale 18.282